Global Anti-Infective Vaccines Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Anti-Infective Vaccines Industry Forecast” looks at past sales and reviews total world Anti-Infective Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-Infective Vaccines sales for 2023 through 2029. With Anti-Infective Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Infective Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Anti-Infective Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Infective Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anti-Infective Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Infective Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Infective Vaccines.
The global Anti-Infective Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anti-Infective Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anti-Infective Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anti-Infective Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anti-Infective Vaccines players cover Emergent BioDefense Operations Lansing Inc., Sanofi Pasteur, Merck & Co., MedImmune LLC, Novartis Vaccines, Diagnostics Ltd., Intercell Biomedical, MassBiologics and Barr Labs, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Infective Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Anti-Infective Vaccines market?
What factors are driving Anti-Infective Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Infective Vaccines market opportunities vary by end market size?
How does Anti-Infective Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Anti-Infective Vaccines Industry Forecast” looks at past sales and reviews total world Anti-Infective Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-Infective Vaccines sales for 2023 through 2029. With Anti-Infective Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Infective Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Anti-Infective Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Infective Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anti-Infective Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Infective Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Infective Vaccines.
The global Anti-Infective Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anti-Infective Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anti-Infective Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anti-Infective Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anti-Infective Vaccines players cover Emergent BioDefense Operations Lansing Inc., Sanofi Pasteur, Merck & Co., MedImmune LLC, Novartis Vaccines, Diagnostics Ltd., Intercell Biomedical, MassBiologics and Barr Labs, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Infective Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Inactivated Vaccines
- Conjugate Vaccines
- Live/attenuated Vaccines
- Bacterial Diseases
- Viral Diseases
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Emergent BioDefense Operations Lansing Inc.
- Sanofi Pasteur
- Merck & Co.
- MedImmune LLC
- Novartis Vaccines
- Diagnostics Ltd.
- Intercell Biomedical
- MassBiologics
- Barr Labs, Inc.
- Organon Teknika Co.
- GlaxoSmithKline Biologicals
- CSL Ltd.
- ID Biomedical Co.
- Protein Sciences Co.
- Wyeth Pharmaceuticals, Inc.
- Berna Biotech
What is the 10-year outlook for the global Anti-Infective Vaccines market?
What factors are driving Anti-Infective Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Infective Vaccines market opportunities vary by end market size?
How does Anti-Infective Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Infective Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anti-Infective Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anti-Infective Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Anti-Infective Vaccines Segment by Type
2.2.1 Inactivated Vaccines
2.2.2 Conjugate Vaccines
2.2.3 Live/attenuated Vaccines
2.3 Anti-Infective Vaccines Sales by Type
2.3.1 Global Anti-Infective Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Anti-Infective Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anti-Infective Vaccines Sale Price by Type (2018-2023)
2.4 Anti-Infective Vaccines Segment by Application
2.4.1 Bacterial Diseases
2.4.2 Viral Diseases
2.5 Anti-Infective Vaccines Sales by Application
2.5.1 Global Anti-Infective Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Anti-Infective Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anti-Infective Vaccines Sale Price by Application (2018-2023)
3 GLOBAL ANTI-INFECTIVE VACCINES BY COMPANY
3.1 Global Anti-Infective Vaccines Breakdown Data by Company
3.1.1 Global Anti-Infective Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Anti-Infective Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Anti-Infective Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Anti-Infective Vaccines Revenue by Company (2018-2023)
3.2.2 Global Anti-Infective Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Anti-Infective Vaccines Sale Price by Company
3.4 Key Manufacturers Anti-Infective Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Infective Vaccines Product Location Distribution
3.4.2 Players Anti-Infective Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTI-INFECTIVE VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Anti-Infective Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Anti-Infective Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anti-Infective Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anti-Infective Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Anti-Infective Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anti-Infective Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anti-Infective Vaccines Sales Growth
4.4 APAC Anti-Infective Vaccines Sales Growth
4.5 Europe Anti-Infective Vaccines Sales Growth
4.6 Middle East & Africa Anti-Infective Vaccines Sales Growth
5 AMERICAS
5.1 Americas Anti-Infective Vaccines Sales by Country
5.1.1 Americas Anti-Infective Vaccines Sales by Country (2018-2023)
5.1.2 Americas Anti-Infective Vaccines Revenue by Country (2018-2023)
5.2 Americas Anti-Infective Vaccines Sales by Type
5.3 Americas Anti-Infective Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Infective Vaccines Sales by Region
6.1.1 APAC Anti-Infective Vaccines Sales by Region (2018-2023)
6.1.2 APAC Anti-Infective Vaccines Revenue by Region (2018-2023)
6.2 APAC Anti-Infective Vaccines Sales by Type
6.3 APAC Anti-Infective Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Infective Vaccines by Country
7.1.1 Europe Anti-Infective Vaccines Sales by Country (2018-2023)
7.1.2 Europe Anti-Infective Vaccines Revenue by Country (2018-2023)
7.2 Europe Anti-Infective Vaccines Sales by Type
7.3 Europe Anti-Infective Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Infective Vaccines by Country
8.1.1 Middle East & Africa Anti-Infective Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anti-Infective Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Anti-Infective Vaccines Sales by Type
8.3 Middle East & Africa Anti-Infective Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Infective Vaccines
10.3 Manufacturing Process Analysis of Anti-Infective Vaccines
10.4 Industry Chain Structure of Anti-Infective Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Infective Vaccines Distributors
11.3 Anti-Infective Vaccines Customer
12 WORLD FORECAST REVIEW FOR ANTI-INFECTIVE VACCINES BY GEOGRAPHIC REGION
12.1 Global Anti-Infective Vaccines Market Size Forecast by Region
12.1.1 Global Anti-Infective Vaccines Forecast by Region (2024-2029)
12.1.2 Global Anti-Infective Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-Infective Vaccines Forecast by Type
12.7 Global Anti-Infective Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Emergent BioDefense Operations Lansing Inc.
13.1.1 Emergent BioDefense Operations Lansing Inc. Company Information
13.1.2 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Portfolios and Specifications
13.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Emergent BioDefense Operations Lansing Inc. Main Business Overview
13.1.5 Emergent BioDefense Operations Lansing Inc. Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Anti-Infective Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Merck & Co.
13.3.1 Merck & Co. Company Information
13.3.2 Merck & Co. Anti-Infective Vaccines Product Portfolios and Specifications
13.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck & Co. Main Business Overview
13.3.5 Merck & Co. Latest Developments
13.4 MedImmune LLC
13.4.1 MedImmune LLC Company Information
13.4.2 MedImmune LLC Anti-Infective Vaccines Product Portfolios and Specifications
13.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 MedImmune LLC Main Business Overview
13.4.5 MedImmune LLC Latest Developments
13.5 Novartis Vaccines
13.5.1 Novartis Vaccines Company Information
13.5.2 Novartis Vaccines Anti-Infective Vaccines Product Portfolios and Specifications
13.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novartis Vaccines Main Business Overview
13.5.5 Novartis Vaccines Latest Developments
13.6 Diagnostics Ltd.
13.6.1 Diagnostics Ltd. Company Information
13.6.2 Diagnostics Ltd. Anti-Infective Vaccines Product Portfolios and Specifications
13.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Diagnostics Ltd. Main Business Overview
13.6.5 Diagnostics Ltd. Latest Developments
13.7 Intercell Biomedical
13.7.1 Intercell Biomedical Company Information
13.7.2 Intercell Biomedical Anti-Infective Vaccines Product Portfolios and Specifications
13.7.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Intercell Biomedical Main Business Overview
13.7.5 Intercell Biomedical Latest Developments
13.8 MassBiologics
13.8.1 MassBiologics Company Information
13.8.2 MassBiologics Anti-Infective Vaccines Product Portfolios and Specifications
13.8.3 MassBiologics Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 MassBiologics Main Business Overview
13.8.5 MassBiologics Latest Developments
13.9 Barr Labs, Inc.
13.9.1 Barr Labs, Inc. Company Information
13.9.2 Barr Labs, Inc. Anti-Infective Vaccines Product Portfolios and Specifications
13.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Barr Labs, Inc. Main Business Overview
13.9.5 Barr Labs, Inc. Latest Developments
13.10 Organon Teknika Co.
13.10.1 Organon Teknika Co. Company Information
13.10.2 Organon Teknika Co. Anti-Infective Vaccines Product Portfolios and Specifications
13.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Organon Teknika Co. Main Business Overview
13.10.5 Organon Teknika Co. Latest Developments
13.11 GlaxoSmithKline Biologicals
13.11.1 GlaxoSmithKline Biologicals Company Information
13.11.2 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Portfolios and Specifications
13.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 GlaxoSmithKline Biologicals Main Business Overview
13.11.5 GlaxoSmithKline Biologicals Latest Developments
13.12 CSL Ltd.
13.12.1 CSL Ltd. Company Information
13.12.2 CSL Ltd. Anti-Infective Vaccines Product Portfolios and Specifications
13.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 CSL Ltd. Main Business Overview
13.12.5 CSL Ltd. Latest Developments
13.13 ID Biomedical Co.
13.13.1 ID Biomedical Co. Company Information
13.13.2 ID Biomedical Co. Anti-Infective Vaccines Product Portfolios and Specifications
13.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 ID Biomedical Co. Main Business Overview
13.13.5 ID Biomedical Co. Latest Developments
13.14 Protein Sciences Co.
13.14.1 Protein Sciences Co. Company Information
13.14.2 Protein Sciences Co. Anti-Infective Vaccines Product Portfolios and Specifications
13.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Protein Sciences Co. Main Business Overview
13.14.5 Protein Sciences Co. Latest Developments
13.15 Wyeth Pharmaceuticals, Inc.
13.15.1 Wyeth Pharmaceuticals, Inc. Company Information
13.15.2 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Portfolios and Specifications
13.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Wyeth Pharmaceuticals, Inc. Main Business Overview
13.15.5 Wyeth Pharmaceuticals, Inc. Latest Developments
13.16 Berna Biotech
13.16.1 Berna Biotech Company Information
13.16.2 Berna Biotech Anti-Infective Vaccines Product Portfolios and Specifications
13.16.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Berna Biotech Main Business Overview
13.16.5 Berna Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Infective Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anti-Infective Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anti-Infective Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Anti-Infective Vaccines Segment by Type
2.2.1 Inactivated Vaccines
2.2.2 Conjugate Vaccines
2.2.3 Live/attenuated Vaccines
2.3 Anti-Infective Vaccines Sales by Type
2.3.1 Global Anti-Infective Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Anti-Infective Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anti-Infective Vaccines Sale Price by Type (2018-2023)
2.4 Anti-Infective Vaccines Segment by Application
2.4.1 Bacterial Diseases
2.4.2 Viral Diseases
2.5 Anti-Infective Vaccines Sales by Application
2.5.1 Global Anti-Infective Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Anti-Infective Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anti-Infective Vaccines Sale Price by Application (2018-2023)
3 GLOBAL ANTI-INFECTIVE VACCINES BY COMPANY
3.1 Global Anti-Infective Vaccines Breakdown Data by Company
3.1.1 Global Anti-Infective Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Anti-Infective Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Anti-Infective Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Anti-Infective Vaccines Revenue by Company (2018-2023)
3.2.2 Global Anti-Infective Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Anti-Infective Vaccines Sale Price by Company
3.4 Key Manufacturers Anti-Infective Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Infective Vaccines Product Location Distribution
3.4.2 Players Anti-Infective Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTI-INFECTIVE VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Anti-Infective Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Anti-Infective Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anti-Infective Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anti-Infective Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Anti-Infective Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anti-Infective Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anti-Infective Vaccines Sales Growth
4.4 APAC Anti-Infective Vaccines Sales Growth
4.5 Europe Anti-Infective Vaccines Sales Growth
4.6 Middle East & Africa Anti-Infective Vaccines Sales Growth
5 AMERICAS
5.1 Americas Anti-Infective Vaccines Sales by Country
5.1.1 Americas Anti-Infective Vaccines Sales by Country (2018-2023)
5.1.2 Americas Anti-Infective Vaccines Revenue by Country (2018-2023)
5.2 Americas Anti-Infective Vaccines Sales by Type
5.3 Americas Anti-Infective Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Infective Vaccines Sales by Region
6.1.1 APAC Anti-Infective Vaccines Sales by Region (2018-2023)
6.1.2 APAC Anti-Infective Vaccines Revenue by Region (2018-2023)
6.2 APAC Anti-Infective Vaccines Sales by Type
6.3 APAC Anti-Infective Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Infective Vaccines by Country
7.1.1 Europe Anti-Infective Vaccines Sales by Country (2018-2023)
7.1.2 Europe Anti-Infective Vaccines Revenue by Country (2018-2023)
7.2 Europe Anti-Infective Vaccines Sales by Type
7.3 Europe Anti-Infective Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Infective Vaccines by Country
8.1.1 Middle East & Africa Anti-Infective Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anti-Infective Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Anti-Infective Vaccines Sales by Type
8.3 Middle East & Africa Anti-Infective Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Infective Vaccines
10.3 Manufacturing Process Analysis of Anti-Infective Vaccines
10.4 Industry Chain Structure of Anti-Infective Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Infective Vaccines Distributors
11.3 Anti-Infective Vaccines Customer
12 WORLD FORECAST REVIEW FOR ANTI-INFECTIVE VACCINES BY GEOGRAPHIC REGION
12.1 Global Anti-Infective Vaccines Market Size Forecast by Region
12.1.1 Global Anti-Infective Vaccines Forecast by Region (2024-2029)
12.1.2 Global Anti-Infective Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-Infective Vaccines Forecast by Type
12.7 Global Anti-Infective Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Emergent BioDefense Operations Lansing Inc.
13.1.1 Emergent BioDefense Operations Lansing Inc. Company Information
13.1.2 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Portfolios and Specifications
13.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Emergent BioDefense Operations Lansing Inc. Main Business Overview
13.1.5 Emergent BioDefense Operations Lansing Inc. Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Anti-Infective Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Merck & Co.
13.3.1 Merck & Co. Company Information
13.3.2 Merck & Co. Anti-Infective Vaccines Product Portfolios and Specifications
13.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck & Co. Main Business Overview
13.3.5 Merck & Co. Latest Developments
13.4 MedImmune LLC
13.4.1 MedImmune LLC Company Information
13.4.2 MedImmune LLC Anti-Infective Vaccines Product Portfolios and Specifications
13.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 MedImmune LLC Main Business Overview
13.4.5 MedImmune LLC Latest Developments
13.5 Novartis Vaccines
13.5.1 Novartis Vaccines Company Information
13.5.2 Novartis Vaccines Anti-Infective Vaccines Product Portfolios and Specifications
13.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novartis Vaccines Main Business Overview
13.5.5 Novartis Vaccines Latest Developments
13.6 Diagnostics Ltd.
13.6.1 Diagnostics Ltd. Company Information
13.6.2 Diagnostics Ltd. Anti-Infective Vaccines Product Portfolios and Specifications
13.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Diagnostics Ltd. Main Business Overview
13.6.5 Diagnostics Ltd. Latest Developments
13.7 Intercell Biomedical
13.7.1 Intercell Biomedical Company Information
13.7.2 Intercell Biomedical Anti-Infective Vaccines Product Portfolios and Specifications
13.7.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Intercell Biomedical Main Business Overview
13.7.5 Intercell Biomedical Latest Developments
13.8 MassBiologics
13.8.1 MassBiologics Company Information
13.8.2 MassBiologics Anti-Infective Vaccines Product Portfolios and Specifications
13.8.3 MassBiologics Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 MassBiologics Main Business Overview
13.8.5 MassBiologics Latest Developments
13.9 Barr Labs, Inc.
13.9.1 Barr Labs, Inc. Company Information
13.9.2 Barr Labs, Inc. Anti-Infective Vaccines Product Portfolios and Specifications
13.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Barr Labs, Inc. Main Business Overview
13.9.5 Barr Labs, Inc. Latest Developments
13.10 Organon Teknika Co.
13.10.1 Organon Teknika Co. Company Information
13.10.2 Organon Teknika Co. Anti-Infective Vaccines Product Portfolios and Specifications
13.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Organon Teknika Co. Main Business Overview
13.10.5 Organon Teknika Co. Latest Developments
13.11 GlaxoSmithKline Biologicals
13.11.1 GlaxoSmithKline Biologicals Company Information
13.11.2 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Portfolios and Specifications
13.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 GlaxoSmithKline Biologicals Main Business Overview
13.11.5 GlaxoSmithKline Biologicals Latest Developments
13.12 CSL Ltd.
13.12.1 CSL Ltd. Company Information
13.12.2 CSL Ltd. Anti-Infective Vaccines Product Portfolios and Specifications
13.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 CSL Ltd. Main Business Overview
13.12.5 CSL Ltd. Latest Developments
13.13 ID Biomedical Co.
13.13.1 ID Biomedical Co. Company Information
13.13.2 ID Biomedical Co. Anti-Infective Vaccines Product Portfolios and Specifications
13.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 ID Biomedical Co. Main Business Overview
13.13.5 ID Biomedical Co. Latest Developments
13.14 Protein Sciences Co.
13.14.1 Protein Sciences Co. Company Information
13.14.2 Protein Sciences Co. Anti-Infective Vaccines Product Portfolios and Specifications
13.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Protein Sciences Co. Main Business Overview
13.14.5 Protein Sciences Co. Latest Developments
13.15 Wyeth Pharmaceuticals, Inc.
13.15.1 Wyeth Pharmaceuticals, Inc. Company Information
13.15.2 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Portfolios and Specifications
13.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Wyeth Pharmaceuticals, Inc. Main Business Overview
13.15.5 Wyeth Pharmaceuticals, Inc. Latest Developments
13.16 Berna Biotech
13.16.1 Berna Biotech Company Information
13.16.2 Berna Biotech Anti-Infective Vaccines Product Portfolios and Specifications
13.16.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Berna Biotech Main Business Overview
13.16.5 Berna Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-Infective Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Anti-Infective Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Inactivated Vaccines
Table 4. Major Players of Conjugate Vaccines
Table 5. Major Players of Live/attenuated Vaccines
Table 6. Global Anti-Infective Vaccines Sales by Type (2018-2023) & (K Units)
Table 7. Global Anti-Infective Vaccines Sales Market Share by Type (2018-2023)
Table 8. Global Anti-Infective Vaccines Revenue by Type (2018-2023) & ($ million)
Table 9. Global Anti-Infective Vaccines Revenue Market Share by Type (2018-2023)
Table 10. Global Anti-Infective Vaccines Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Anti-Infective Vaccines Sales by Application (2018-2023) & (K Units)
Table 12. Global Anti-Infective Vaccines Sales Market Share by Application (2018-2023)
Table 13. Global Anti-Infective Vaccines Revenue by Application (2018-2023)
Table 14. Global Anti-Infective Vaccines Revenue Market Share by Application (2018-2023)
Table 15. Global Anti-Infective Vaccines Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Anti-Infective Vaccines Sales by Company (2018-2023) & (K Units)
Table 17. Global Anti-Infective Vaccines Sales Market Share by Company (2018-2023)
Table 18. Global Anti-Infective Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Anti-Infective Vaccines Revenue Market Share by Company (2018-2023)
Table 20. Global Anti-Infective Vaccines Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Anti-Infective Vaccines Producing Area Distribution and Sales Area
Table 22. Players Anti-Infective Vaccines Products Offered
Table 23. Anti-Infective Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Anti-Infective Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Anti-Infective Vaccines Sales Market Share Geographic Region (2018-2023)
Table 28. Global Anti-Infective Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Anti-Infective Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Anti-Infective Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Anti-Infective Vaccines Sales Market Share by Country/Region (2018-2023)
Table 32. Global Anti-Infective Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Anti-Infective Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Anti-Infective Vaccines Sales by Country (2018-2023) & (K Units)
Table 35. Americas Anti-Infective Vaccines Sales Market Share by Country (2018-2023)
Table 36. Americas Anti-Infective Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Anti-Infective Vaccines Revenue Market Share by Country (2018-2023)
Table 38. Americas Anti-Infective Vaccines Sales by Type (2018-2023) & (K Units)
Table 39. Americas Anti-Infective Vaccines Sales by Application (2018-2023) & (K Units)
Table 40. APAC Anti-Infective Vaccines Sales by Region (2018-2023) & (K Units)
Table 41. APAC Anti-Infective Vaccines Sales Market Share by Region (2018-2023)
Table 42. APAC Anti-Infective Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Anti-Infective Vaccines Revenue Market Share by Region (2018-2023)
Table 44. APAC Anti-Infective Vaccines Sales by Type (2018-2023) & (K Units)
Table 45. APAC Anti-Infective Vaccines Sales by Application (2018-2023) & (K Units)
Table 46. Europe Anti-Infective Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Europe Anti-Infective Vaccines Sales Market Share by Country (2018-2023)
Table 48. Europe Anti-Infective Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Anti-Infective Vaccines Revenue Market Share by Country (2018-2023)
Table 50. Europe Anti-Infective Vaccines Sales by Type (2018-2023) & (K Units)
Table 51. Europe Anti-Infective Vaccines Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Anti-Infective Vaccines Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Anti-Infective Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Anti-Infective Vaccines Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Anti-Infective Vaccines Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Anti-Infective Vaccines Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Anti-Infective Vaccines
Table 59. Key Market Challenges & Risks of Anti-Infective Vaccines
Table 60. Key Industry Trends of Anti-Infective Vaccines
Table 61. Anti-Infective Vaccines Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Anti-Infective Vaccines Distributors List
Table 64. Anti-Infective Vaccines Customer List
Table 65. Global Anti-Infective Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Anti-Infective Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Anti-Infective Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Anti-Infective Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Anti-Infective Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Anti-Infective Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Anti-Infective Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Anti-Infective Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Anti-Infective Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Anti-Infective Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Anti-Infective Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Anti-Infective Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Anti-Infective Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Anti-Infective Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Emergent BioDefense Operations Lansing Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Portfolios and Specifications
Table 81. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Emergent BioDefense Operations Lansing Inc. Main Business
Table 83. Emergent BioDefense Operations Lansing Inc. Latest Developments
Table 84. Sanofi Pasteur Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofi Pasteur Anti-Infective Vaccines Product Portfolios and Specifications
Table 86. Sanofi Pasteur Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Sanofi Pasteur Main Business
Table 88. Sanofi Pasteur Latest Developments
Table 89. Merck & Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Merck & Co. Anti-Infective Vaccines Product Portfolios and Specifications
Table 91. Merck & Co. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Merck & Co. Main Business
Table 93. Merck & Co. Latest Developments
Table 94. MedImmune LLC Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. MedImmune LLC Anti-Infective Vaccines Product Portfolios and Specifications
Table 96. MedImmune LLC Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. MedImmune LLC Main Business
Table 98. MedImmune LLC Latest Developments
Table 99. Novartis Vaccines Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Novartis Vaccines Anti-Infective Vaccines Product Portfolios and Specifications
Table 101. Novartis Vaccines Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Novartis Vaccines Main Business
Table 103. Novartis Vaccines Latest Developments
Table 104. Diagnostics Ltd. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Diagnostics Ltd. Anti-Infective Vaccines Product Portfolios and Specifications
Table 106. Diagnostics Ltd. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Diagnostics Ltd. Main Business
Table 108. Diagnostics Ltd. Latest Developments
Table 109. Intercell Biomedical Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. Intercell Biomedical Anti-Infective Vaccines Product Portfolios and Specifications
Table 111. Intercell Biomedical Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Intercell Biomedical Main Business
Table 113. Intercell Biomedical Latest Developments
Table 114. MassBiologics Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 115. MassBiologics Anti-Infective Vaccines Product Portfolios and Specifications
Table 116. MassBiologics Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. MassBiologics Main Business
Table 118. MassBiologics Latest Developments
Table 119. Barr Labs, Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120. Barr Labs, Inc. Anti-Infective Vaccines Product Portfolios and Specifications
Table 121. Barr Labs, Inc. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Barr Labs, Inc. Main Business
Table 123. Barr Labs, Inc. Latest Developments
Table 124. Organon Teknika Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. Organon Teknika Co. Anti-Infective Vaccines Product Portfolios and Specifications
Table 126. Organon Teknika Co. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Organon Teknika Co. Main Business
Table 128. Organon Teknika Co. Latest Developments
Table 129. GlaxoSmithKline Biologicals Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 130. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Portfolios and Specifications
Table 131. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. GlaxoSmithKline Biologicals Main Business
Table 133. GlaxoSmithKline Biologicals Latest Developments
Table 134. CSL Ltd. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 135. CSL Ltd. Anti-Infective Vaccines Product Portfolios and Specifications
Table 136. CSL Ltd. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. CSL Ltd. Main Business
Table 138. CSL Ltd. Latest Developments
Table 139. ID Biomedical Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 140. ID Biomedical Co. Anti-Infective Vaccines Product Portfolios and Specifications
Table 141. ID Biomedical Co. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. ID Biomedical Co. Main Business
Table 143. ID Biomedical Co. Latest Developments
Table 144. Protein Sciences Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 145. Protein Sciences Co. Anti-Infective Vaccines Product Portfolios and Specifications
Table 146. Protein Sciences Co. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Protein Sciences Co. Main Business
Table 148. Protein Sciences Co. Latest Developments
Table 149. Wyeth Pharmaceuticals, Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 150. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Portfolios and Specifications
Table 151. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Wyeth Pharmaceuticals, Inc. Main Business
Table 153. Wyeth Pharmaceuticals, Inc. Latest Developments
Table 154. Berna Biotech Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 155. Berna Biotech Anti-Infective Vaccines Product Portfolios and Specifications
Table 156. Berna Biotech Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Berna Biotech Main Business
Table 158. Berna Biotech Latest Developments
Table 1. Anti-Infective Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Anti-Infective Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Inactivated Vaccines
Table 4. Major Players of Conjugate Vaccines
Table 5. Major Players of Live/attenuated Vaccines
Table 6. Global Anti-Infective Vaccines Sales by Type (2018-2023) & (K Units)
Table 7. Global Anti-Infective Vaccines Sales Market Share by Type (2018-2023)
Table 8. Global Anti-Infective Vaccines Revenue by Type (2018-2023) & ($ million)
Table 9. Global Anti-Infective Vaccines Revenue Market Share by Type (2018-2023)
Table 10. Global Anti-Infective Vaccines Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Anti-Infective Vaccines Sales by Application (2018-2023) & (K Units)
Table 12. Global Anti-Infective Vaccines Sales Market Share by Application (2018-2023)
Table 13. Global Anti-Infective Vaccines Revenue by Application (2018-2023)
Table 14. Global Anti-Infective Vaccines Revenue Market Share by Application (2018-2023)
Table 15. Global Anti-Infective Vaccines Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Anti-Infective Vaccines Sales by Company (2018-2023) & (K Units)
Table 17. Global Anti-Infective Vaccines Sales Market Share by Company (2018-2023)
Table 18. Global Anti-Infective Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Anti-Infective Vaccines Revenue Market Share by Company (2018-2023)
Table 20. Global Anti-Infective Vaccines Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Anti-Infective Vaccines Producing Area Distribution and Sales Area
Table 22. Players Anti-Infective Vaccines Products Offered
Table 23. Anti-Infective Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Anti-Infective Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Anti-Infective Vaccines Sales Market Share Geographic Region (2018-2023)
Table 28. Global Anti-Infective Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Anti-Infective Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Anti-Infective Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Anti-Infective Vaccines Sales Market Share by Country/Region (2018-2023)
Table 32. Global Anti-Infective Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Anti-Infective Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Anti-Infective Vaccines Sales by Country (2018-2023) & (K Units)
Table 35. Americas Anti-Infective Vaccines Sales Market Share by Country (2018-2023)
Table 36. Americas Anti-Infective Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Anti-Infective Vaccines Revenue Market Share by Country (2018-2023)
Table 38. Americas Anti-Infective Vaccines Sales by Type (2018-2023) & (K Units)
Table 39. Americas Anti-Infective Vaccines Sales by Application (2018-2023) & (K Units)
Table 40. APAC Anti-Infective Vaccines Sales by Region (2018-2023) & (K Units)
Table 41. APAC Anti-Infective Vaccines Sales Market Share by Region (2018-2023)
Table 42. APAC Anti-Infective Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Anti-Infective Vaccines Revenue Market Share by Region (2018-2023)
Table 44. APAC Anti-Infective Vaccines Sales by Type (2018-2023) & (K Units)
Table 45. APAC Anti-Infective Vaccines Sales by Application (2018-2023) & (K Units)
Table 46. Europe Anti-Infective Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Europe Anti-Infective Vaccines Sales Market Share by Country (2018-2023)
Table 48. Europe Anti-Infective Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Anti-Infective Vaccines Revenue Market Share by Country (2018-2023)
Table 50. Europe Anti-Infective Vaccines Sales by Type (2018-2023) & (K Units)
Table 51. Europe Anti-Infective Vaccines Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Anti-Infective Vaccines Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Anti-Infective Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Anti-Infective Vaccines Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Anti-Infective Vaccines Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Anti-Infective Vaccines Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Anti-Infective Vaccines
Table 59. Key Market Challenges & Risks of Anti-Infective Vaccines
Table 60. Key Industry Trends of Anti-Infective Vaccines
Table 61. Anti-Infective Vaccines Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Anti-Infective Vaccines Distributors List
Table 64. Anti-Infective Vaccines Customer List
Table 65. Global Anti-Infective Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Anti-Infective Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Anti-Infective Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Anti-Infective Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Anti-Infective Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Anti-Infective Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Anti-Infective Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Anti-Infective Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Anti-Infective Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Anti-Infective Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Anti-Infective Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Anti-Infective Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Anti-Infective Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Anti-Infective Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Emergent BioDefense Operations Lansing Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Portfolios and Specifications
Table 81. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Emergent BioDefense Operations Lansing Inc. Main Business
Table 83. Emergent BioDefense Operations Lansing Inc. Latest Developments
Table 84. Sanofi Pasteur Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofi Pasteur Anti-Infective Vaccines Product Portfolios and Specifications
Table 86. Sanofi Pasteur Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Sanofi Pasteur Main Business
Table 88. Sanofi Pasteur Latest Developments
Table 89. Merck & Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Merck & Co. Anti-Infective Vaccines Product Portfolios and Specifications
Table 91. Merck & Co. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Merck & Co. Main Business
Table 93. Merck & Co. Latest Developments
Table 94. MedImmune LLC Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. MedImmune LLC Anti-Infective Vaccines Product Portfolios and Specifications
Table 96. MedImmune LLC Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. MedImmune LLC Main Business
Table 98. MedImmune LLC Latest Developments
Table 99. Novartis Vaccines Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Novartis Vaccines Anti-Infective Vaccines Product Portfolios and Specifications
Table 101. Novartis Vaccines Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Novartis Vaccines Main Business
Table 103. Novartis Vaccines Latest Developments
Table 104. Diagnostics Ltd. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Diagnostics Ltd. Anti-Infective Vaccines Product Portfolios and Specifications
Table 106. Diagnostics Ltd. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Diagnostics Ltd. Main Business
Table 108. Diagnostics Ltd. Latest Developments
Table 109. Intercell Biomedical Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. Intercell Biomedical Anti-Infective Vaccines Product Portfolios and Specifications
Table 111. Intercell Biomedical Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Intercell Biomedical Main Business
Table 113. Intercell Biomedical Latest Developments
Table 114. MassBiologics Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 115. MassBiologics Anti-Infective Vaccines Product Portfolios and Specifications
Table 116. MassBiologics Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. MassBiologics Main Business
Table 118. MassBiologics Latest Developments
Table 119. Barr Labs, Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120. Barr Labs, Inc. Anti-Infective Vaccines Product Portfolios and Specifications
Table 121. Barr Labs, Inc. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Barr Labs, Inc. Main Business
Table 123. Barr Labs, Inc. Latest Developments
Table 124. Organon Teknika Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. Organon Teknika Co. Anti-Infective Vaccines Product Portfolios and Specifications
Table 126. Organon Teknika Co. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Organon Teknika Co. Main Business
Table 128. Organon Teknika Co. Latest Developments
Table 129. GlaxoSmithKline Biologicals Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 130. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Portfolios and Specifications
Table 131. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. GlaxoSmithKline Biologicals Main Business
Table 133. GlaxoSmithKline Biologicals Latest Developments
Table 134. CSL Ltd. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 135. CSL Ltd. Anti-Infective Vaccines Product Portfolios and Specifications
Table 136. CSL Ltd. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. CSL Ltd. Main Business
Table 138. CSL Ltd. Latest Developments
Table 139. ID Biomedical Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 140. ID Biomedical Co. Anti-Infective Vaccines Product Portfolios and Specifications
Table 141. ID Biomedical Co. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. ID Biomedical Co. Main Business
Table 143. ID Biomedical Co. Latest Developments
Table 144. Protein Sciences Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 145. Protein Sciences Co. Anti-Infective Vaccines Product Portfolios and Specifications
Table 146. Protein Sciences Co. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Protein Sciences Co. Main Business
Table 148. Protein Sciences Co. Latest Developments
Table 149. Wyeth Pharmaceuticals, Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 150. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Portfolios and Specifications
Table 151. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Wyeth Pharmaceuticals, Inc. Main Business
Table 153. Wyeth Pharmaceuticals, Inc. Latest Developments
Table 154. Berna Biotech Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 155. Berna Biotech Anti-Infective Vaccines Product Portfolios and Specifications
Table 156. Berna Biotech Anti-Infective Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Berna Biotech Main Business
Table 158. Berna Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-Infective Vaccines
Figure 2. Anti-Infective Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Infective Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Anti-Infective Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Anti-Infective Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Inactivated Vaccines
Figure 10. Product Picture of Conjugate Vaccines
Figure 11. Product Picture of Live/attenuated Vaccines
Figure 12. Global Anti-Infective Vaccines Sales Market Share by Type in 2022
Figure 13. Global Anti-Infective Vaccines Revenue Market Share by Type (2018-2023)
Figure 14. Anti-Infective Vaccines Consumed in Bacterial Diseases
Figure 15. Global Anti-Infective Vaccines Market: Bacterial Diseases (2018-2023) & (K Units)
Figure 16. Anti-Infective Vaccines Consumed in Viral Diseases
Figure 17. Global Anti-Infective Vaccines Market: Viral Diseases (2018-2023) & (K Units)
Figure 18. Global Anti-Infective Vaccines Sales Market Share by Application (2022)
Figure 19. Global Anti-Infective Vaccines Revenue Market Share by Application in 2022
Figure 20. Anti-Infective Vaccines Sales Market by Company in 2022 (K Units)
Figure 21. Global Anti-Infective Vaccines Sales Market Share by Company in 2022
Figure 22. Anti-Infective Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Anti-Infective Vaccines Revenue Market Share by Company in 2022
Figure 24. Global Anti-Infective Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Anti-Infective Vaccines Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Anti-Infective Vaccines Sales 2018-2023 (K Units)
Figure 27. Americas Anti-Infective Vaccines Revenue 2018-2023 ($ Millions)
Figure 28. APAC Anti-Infective Vaccines Sales 2018-2023 (K Units)
Figure 29. APAC Anti-Infective Vaccines Revenue 2018-2023 ($ Millions)
Figure 30. Europe Anti-Infective Vaccines Sales 2018-2023 (K Units)
Figure 31. Europe Anti-Infective Vaccines Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Anti-Infective Vaccines Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Anti-Infective Vaccines Revenue 2018-2023 ($ Millions)
Figure 34. Americas Anti-Infective Vaccines Sales Market Share by Country in 2022
Figure 35. Americas Anti-Infective Vaccines Revenue Market Share by Country in 2022
Figure 36. Americas Anti-Infective Vaccines Sales Market Share by Type (2018-2023)
Figure 37. Americas Anti-Infective Vaccines Sales Market Share by Application (2018-2023)
Figure 38. United States Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Anti-Infective Vaccines Sales Market Share by Region in 2022
Figure 43. APAC Anti-Infective Vaccines Revenue Market Share by Regions in 2022
Figure 44. APAC Anti-Infective Vaccines Sales Market Share by Type (2018-2023)
Figure 45. APAC Anti-Infective Vaccines Sales Market Share by Application (2018-2023)
Figure 46. China Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Anti-Infective Vaccines Sales Market Share by Country in 2022
Figure 54. Europe Anti-Infective Vaccines Revenue Market Share by Country in 2022
Figure 55. Europe Anti-Infective Vaccines Sales Market Share by Type (2018-2023)
Figure 56. Europe Anti-Infective Vaccines Sales Market Share by Application (2018-2023)
Figure 57. Germany Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Anti-Infective Vaccines Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Application (2018-2023)
Figure 66. Egypt Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Anti-Infective Vaccines in 2022
Figure 72. Manufacturing Process Analysis of Anti-Infective Vaccines
Figure 73. Industry Chain Structure of Anti-Infective Vaccines
Figure 74. Channels of Distribution
Figure 75. Global Anti-Infective Vaccines Sales Market Forecast by Region (2024-2029)
Figure 76. Global Anti-Infective Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Anti-Infective Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Anti-Infective Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Anti-Infective Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Anti-Infective Vaccines Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Anti-Infective Vaccines
Figure 2. Anti-Infective Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Infective Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Anti-Infective Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Anti-Infective Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Inactivated Vaccines
Figure 10. Product Picture of Conjugate Vaccines
Figure 11. Product Picture of Live/attenuated Vaccines
Figure 12. Global Anti-Infective Vaccines Sales Market Share by Type in 2022
Figure 13. Global Anti-Infective Vaccines Revenue Market Share by Type (2018-2023)
Figure 14. Anti-Infective Vaccines Consumed in Bacterial Diseases
Figure 15. Global Anti-Infective Vaccines Market: Bacterial Diseases (2018-2023) & (K Units)
Figure 16. Anti-Infective Vaccines Consumed in Viral Diseases
Figure 17. Global Anti-Infective Vaccines Market: Viral Diseases (2018-2023) & (K Units)
Figure 18. Global Anti-Infective Vaccines Sales Market Share by Application (2022)
Figure 19. Global Anti-Infective Vaccines Revenue Market Share by Application in 2022
Figure 20. Anti-Infective Vaccines Sales Market by Company in 2022 (K Units)
Figure 21. Global Anti-Infective Vaccines Sales Market Share by Company in 2022
Figure 22. Anti-Infective Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Anti-Infective Vaccines Revenue Market Share by Company in 2022
Figure 24. Global Anti-Infective Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Anti-Infective Vaccines Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Anti-Infective Vaccines Sales 2018-2023 (K Units)
Figure 27. Americas Anti-Infective Vaccines Revenue 2018-2023 ($ Millions)
Figure 28. APAC Anti-Infective Vaccines Sales 2018-2023 (K Units)
Figure 29. APAC Anti-Infective Vaccines Revenue 2018-2023 ($ Millions)
Figure 30. Europe Anti-Infective Vaccines Sales 2018-2023 (K Units)
Figure 31. Europe Anti-Infective Vaccines Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Anti-Infective Vaccines Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Anti-Infective Vaccines Revenue 2018-2023 ($ Millions)
Figure 34. Americas Anti-Infective Vaccines Sales Market Share by Country in 2022
Figure 35. Americas Anti-Infective Vaccines Revenue Market Share by Country in 2022
Figure 36. Americas Anti-Infective Vaccines Sales Market Share by Type (2018-2023)
Figure 37. Americas Anti-Infective Vaccines Sales Market Share by Application (2018-2023)
Figure 38. United States Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Anti-Infective Vaccines Sales Market Share by Region in 2022
Figure 43. APAC Anti-Infective Vaccines Revenue Market Share by Regions in 2022
Figure 44. APAC Anti-Infective Vaccines Sales Market Share by Type (2018-2023)
Figure 45. APAC Anti-Infective Vaccines Sales Market Share by Application (2018-2023)
Figure 46. China Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Anti-Infective Vaccines Sales Market Share by Country in 2022
Figure 54. Europe Anti-Infective Vaccines Revenue Market Share by Country in 2022
Figure 55. Europe Anti-Infective Vaccines Sales Market Share by Type (2018-2023)
Figure 56. Europe Anti-Infective Vaccines Sales Market Share by Application (2018-2023)
Figure 57. Germany Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Anti-Infective Vaccines Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Application (2018-2023)
Figure 66. Egypt Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Anti-Infective Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Anti-Infective Vaccines in 2022
Figure 72. Manufacturing Process Analysis of Anti-Infective Vaccines
Figure 73. Industry Chain Structure of Anti-Infective Vaccines
Figure 74. Channels of Distribution
Figure 75. Global Anti-Infective Vaccines Sales Market Forecast by Region (2024-2029)
Figure 76. Global Anti-Infective Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Anti-Infective Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Anti-Infective Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Anti-Infective Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Anti-Infective Vaccines Revenue Market Share Forecast by Application (2024-2029)
